Endothelial proliferation, neoangiogenesis, and potential de novo generation of cerebrovascular malformations

Journal of Neurosurgery

Volumn 94, Issue 6, 2001, Pages 972-977

  Sure, Ulrich ^b   Butz, Nick ^b   Schlegel, Jürgen ^b   Siegel, Adrian M ^b   Wakat, Jörg P ^b   Mennel, Hans D ^b   Bien, Siegfried ^b   Bertalanffy, Helmut ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b NONE

Author keywords

Arteriovenous malformation; Cavernoma; Endothelium; Immunohistochemistry

Indexed keywords

CYCLINE; MONOCLONAL ANTIBODY KI 67; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ANGIOGENESIS; ARTERIOVENOUS MALFORMATION; ARTICLE; ARTIFICIAL EMBOLISM; CAVERNOUS SINUS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GERMANY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT DISEASE; SCHOOL CHILD; VASCULAR ENDOTHELIUM;

EID: 0034866624     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2001.94.6.0972     Document Type: Article

References (48)

1. Spontaneous angiographic obliteration of cerebral arteriovenous malformations
2. Arteriovenous malformations of the brain in adults
3. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms
4. Microsurgery of deep-seated cavernous angiomas: Report of 26 cases
5. Indications for surgery and prognosis in patients with cerebral cavernous angiomas
6. Familial cavernous angioma, of the brain stem dominantly inherited in Hispanics
7. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation
8. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas
9. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections
10. Arteriovenous malformations of the brain: Natural history in unoperated patients
11. De novo formation of a central nervous system cavernous malformation: Implications for predicting risk of hemorrhage. Case report and review of the literature
12. Radiation-induced cavernous malformation
13. A gene responsible for cavernous malformations of the brain maps to chromosome 7q
14. Natural history of arteriovenous malformations of the brain: A clinical study
15. The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor
16. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67
17. A founder mutation as a cause of cerebral cavernous malformation in Hispanic Americans
18. Genetic heterogeneity of inherited cerebral cavernous malformation
19. Recurrence of an excised cavernous hemangioma in the opposite cerebral hemisphere. Case report
20. Regulation of DNA replication and repair proteins through interaction with the front side of proliferating cell nuclear antigen
21. Recurrent cerebral arteriovenous malformations after negative postoperative angiograms
22. Image cytometric measurement of nuclear proliferation markers (MIB-1, PCNA) in astrocytomas. Prognostic significance
23. Arteriovenous malformations of the brain in children: A forty year experience
24. The natural history of cerebral cavernous malformations
25. Formation of intracerebral cavernous malformations after radiation treatment for central nervous system neoplasia in children
26. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis
27. The natural history of cavernous malformations: A prospective study of 68 patients
28. Embryological basis of some aspects of cerebral vascular fistulas and malformations
29. Proliferating cell nuclear antigen (PCNA) in cerebral cavernomas: An immunocytochemical study of 42 cases
30. NYK/FLK-1: A putative receptor protein tyrosine kinase isolated from E10 embryonic neuroepithelium is expressed in endothelial cells of the developing embryo
31. The natural history of symptomatic arteriovenous malformations of the brain: A 24-year follow-up assessment
32. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth
33. Mechanisms of angiogenesis in the brain
34. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis
35. Cerebral cavernous malformations: Natural history and prognosis after clinical deterioration with or without hemorrhage
36. Growth, subsequent bleeding, and de novo appearance of cerebral cavernous angiomas
37. Occult cerebro-vascular malformations after irradiation
38. Cavernous malformations and capillary telangiectasia: A spectrum within a single pathological entity
39. Recurrence in a different location of a cerebral arteriovenous malformation in a child after radiosurgery
40. Ossified and de novo cavernous malformations in the same patient
41. Cavernous angiomas in the central nervous system in children
42. Familial cavernous angioma: An unknown, known disease
43. Anticipation in familial cavernous angioma: A study of 52 families from International Familial Cavernous Angioma Study
44. Expression of vascular endothelial growth factor in pediatric and adult cerebral arteriovenous malformations: An immunocytochemical study
45. A proposed grading system for arteriovenous malformations
46. Enlargement of an arteriovenous malformation documented by angiography. Case report
47. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes
48. The change in size of intracranial arteriovenous malformations